BioSkryb
VerifiedBioSkryb is a developer of genomic amplification technologies that deliver unprecedented coverage for various gene sequencing applications.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$46—69m (Dealroom.co estimates Jan 2020.)
Durham North Carolina (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | $0.0 | round | |
| investor | $0.0 | round | |
$10.0m | Convertible | ||
| Total Funding | 000k | ||
Related Content
Recent News about BioSkryb
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.